{"version":"1.0","type":"link","title":"Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 study.","author_name":"Zou L 외","author_url":"https://prs-insight.online/author/Zou%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/82158","thumbnail_width":1200,"thumbnail_height":630}